| Oct 27, 2025 |
Oct 28, 2025 |
Viking Therapeutics, Inc.
|
COO |
Sell |
82.5
|
+4,932
|
1.31%
|
✗
|
$216.5K |
| Jul 2, 2025 |
Jul 3, 2025 |
Viking Therapeutics, Inc.
|
COO |
Sell |
72.5
|
+3,401
|
0.91%
|
✗
|
$118.5K |
| Jan 3, 2025 |
Jan 6, 2025 |
Viking Therapeutics, Inc.
|
COO |
Sell |
92.5
|
+11,985
|
3.31%
|
✗
|
$2.3M |
| Jul 29, 2024 |
Jul 31, 2024 |
Viking Therapeutics, Inc.
|
COO |
Sell |
92.5
|
+13,641
|
3.91%
|
✗
|
$1M |
| May 1, 2024 |
May 2, 2024 |
Viking Therapeutics, Inc.
|
COO |
Sell |
2.5
|
-281,425
|
-44.68%
|
✓
|
$22.1M |
| Mar 27, 2024 |
Mar 27, 2024 |
Viking Therapeutics, Inc.
|
COO |
Sell |
92.5
|
+15,057
|
4.32%
|
✗
|
$1.4M |
| Mar 1, 2024 |
Mar 4, 2024 |
Viking Therapeutics, Inc.
|
COO |
Sell |
92.5
|
+14,709
|
4.41%
|
✗
|
$1.4M |
| Jan 3, 2024 |
Jan 4, 2024 |
Viking Therapeutics, Inc.
|
COO |
Sell |
100.0
|
+34,925
|
11.69%
|
✗
|
$1.1M |
| Apr 17, 2023 |
Apr 18, 2023 |
Viking Therapeutics, Inc.
|
COO |
Sell |
35.0
|
-12,500
|
-4.16%
|
✓
|
$250K |
| Mar 30, 2023 |
Apr 3, 2023 |
Viking Therapeutics, Inc.
|
COO |
Sell |
92.5
|
+25,868
|
9.88%
|
✓
|
$541.1K |
| Mar 28, 2023 |
Mar 30, 2023 |
Viking Therapeutics, Inc.
|
COO |
Sell |
5.0
|
-237,805
|
-30.18%
|
✓
|
$3.6M |
| Jan 15, 2023 |
Jan 17, 2023 |
Viking Therapeutics, Inc.
|
COO |
Sell |
52.5
|
-1,079
|
-0.34%
|
✗
|
$9.7K |
| Dec 30, 2022 |
Jan 4, 2023 |
Viking Therapeutics, Inc.
|
COO |
Sell |
97.5
|
+68,546
|
27.44%
|
✗
|
$398.5K |
| Jan 15, 2022 |
Feb 11, 2022 |
Viking Therapeutics, Inc.
|
COO |
Sell |
52.5
|
-827
|
-0.35%
|
✗
|
$3.5K |
| Jan 3, 2022 |
Jan 5, 2022 |
Viking Therapeutics, Inc.
|
COO |
Sell |
95.0
|
+61,569
|
34.60%
|
✗
|
$73.8K |
| Sep 28, 2021 |
Sep 30, 2021 |
Viking Therapeutics, Inc.
|
COO |
Sell |
78.8
|
+3,828
|
2.20%
|
✗
|
$18.5K |
| Jan 15, 2021 |
Jan 19, 2021 |
Viking Therapeutics, Inc.
|
COO |
Sell |
48.8
|
-1,680
|
-0.98%
|
✗
|
$11.1K |
| Jan 4, 2021 |
Jan 6, 2021 |
Viking Therapeutics, Inc.
|
COO |
Sell |
91.3
|
+76,977
|
81.32%
|
✗
|
$16.1K |